Email Updates

Search form

You are here

AVAC in the News

  • A vaccine for HIV has been sought since the early days of the epidemic. After years of difficulties and setbacks, several new approaches are providing cause for optimism.

    April 1, 2017
    Lancet
  • Today, the National LGBTQ Task Force joined 40 national organizations in taking part in a protest in front of the White House against President Donald Trump’s global gag rule.

    March 8, 2017
    LGBT Weekly
  • One benefit of this “test and treat” approach.... is that it reduces the amount of virus in carriers’ bodies and so lowers their chances of passing it on....But despite big health benefits, the “test and treat” approach throws up new challenges for countries with large HIV epidemics.

    March 2, 2017
    The Guardian
  • A new vaccine-based treatment for HIV has succeeded in suppressing the virus in five patients, raising hopes further research could help prevent AIDS without the need for daily drugs. Researchers combined two innovative HIV vaccines with a drug usually used to treat cancer in the trial... After receiving the treatment, the virus was undetectable in five out of 24 participants and its spread was stopped by their immune systems, reported the New Scientist. One of them has been drug-free for seven months.

    February 24, 2017
    Independent
  • The battle to save the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) is already well under way, just one month after President Donald J. Trump’s inauguration and his almost immediate reinstatement of the country's global gag order on foreign funding for comprehensive sexual health services.

    February 22, 2017
    General
    POZ
  • “The last person that I train, I want that training to be in something other than HIV”, says Jared Baeten. Speaking to The Lancet Infectious Diseases from the HIV Research for Prevention Conference (HIVR4P) in Chicago, IL, USA, where he has brought a 12-strong team of his researchers, Baeten explains: “When that time comes, I want HIV to have been eliminated as public health threat, so we can focus on other diseases”.

    January 3, 2017
    Lancet
  • Voice of America interviews AVAC’s Mitchell Warren about the success of PEPFAR under Obama and Bush. Listen and learn about the potential for continued success if this high-impact program gets robust funding under the next presidential administration.

    December 30, 2016
    General
    Voice of America
  • A Boston-based biotech company will partner with the Bill and Melinda Gates Foundation in a $140 million effort to prevent HIV in sub-Saharan Africa.

    December 30, 2016
    Boston Herald
  • This Wall Street Journal article quotes AVAC's Mitchell Warren in this story about a promising innovation in HIV prevention: a match-stick size implantable drug pump for delivering PrEP.

    December 29, 2016
    The Wall Street Journal
  • On the occasion of World AIDS Day, Devex interviews AVAC Executive Director Mitchell Warren to speak about best utilizing existing tools for treatment and prevention and the development of additional tools for the future.

    December 1, 2016
    General
    Devex

Pages